Involving 46 countries! Nestlé announces a large-scale global recall of infant formula, possibly facing 1.2 billion Swiss francs in sales losses.

```

Nestlé's large-scale global recall of infant formula milk powder is rapidly unfolding into a severe crisis of trust and financial challenge.

This recall spans 46 countries, involving several core brands such as NAN and BEBA. Analysts estimate the move may result in sales losses of up to 1.2 billion Swiss francs (around $1.35 billion), a figure that not only directly impacts Nestlé's short-term revenue but also poses a serious test to its long-term reputation in the sensitive infant nutrition market.

The incident began on Monday when Nestlé initially announced a recall of certain product batches in Europe, suspecting contamination by toxins produced by Bacillus cereus that could cause nausea and vomiting. Subsequently, the scope of the recall quickly expanded within the week to Asia, Latin America, the Middle East, and Africa, ultimately covering 46 markets. According to CCTV News, China's State Food Safety Office and the State Administration for Market Regulation immediately urged Nestlé (China) Ltd. to fulfill its responsibilities, and the company has since implemented the relevant batch recalls in China as required.

Although Nestlé states that no illness reports have been linked to the affected products so far and insists that the recalled products account for "far less than 0.5%" of its annual sales, expecting the financial impact to be minimal, market response has not calmed. Jefferies estimates that about 1.3% of group sales may be affected, with risk exposure amounting to 1.2 billion Swiss francs. Barclays analyst Warren Ackerman gave a similar assessment, believing the total risk to account for about 0.8% to 1.5% of group sales. So far this year, Nestlé's share price has fallen by 5.07%.

The recall represents a major setback for Nestlé's new CEO Philipp Navratil. Navratil took over last September from predecessor Laurent Freixe, who was dismissed for "failing to disclose a romantic relationship with a subordinate," and has been working to rebuild investor trust, restore growth, and reduce debt, including plans to cut 16,000 jobs over the next two years. However, successive operational issues are eroding investor patience, and this recall has undoubtedly heightened market concerns about the Swiss food giant's execution and internal control capabilities.

Analysts Warn: Reputational Damage Worse than Financial Hit

Compared to the direct sales losses, market analysts are more worried about the lasting damage to Nestlé's brand reputation caused by this incident.

Vontobel analyst Jean-Philippe Bertschy points out that reputation risk is an even greater danger than financial impact. He said:

This incident has left people disappointed in Nestlé's execution and communication skills, which should have been key priorities for the new leadership. For investors, this is far from reassuring and has reignited concerns about management capabilities in a category that is extremely sensitive to reputation.

Previously, Nestlé has faced mounting pressure from a series of compliance and operational issues. Last July, French authorities raided Nestlé's offices to investigate allegations over unauthorized filtration methods used in its bottled mineral water. Additionally, last year the company was forced to recall frozen meals in the U.S. due to contamination concerns. The accumulation of these events has further intensified questions about its corporate governance.

Contamination Traced to Ingredient Oil, National Differences in Market Reaction

Regarding the specific cause of the contamination, Nestlé explained that routine tests revealed a quality problem with a formula ingredient—arachidonic acid oil. The brands involved in this recall include well-known product lines such as NAN, BEBA, Guigoz, SMA, and Alfamino.

As for future market recovery, analysts believe consumer reactions will differ significantly across countries. Jefferies analyst David Hayes specifically pointed out the potential risk in the Chinese market, citing the 2013 recall of Danone's Dumex brand, which led to a loss of 800 million euros in sales for Danone in China.

By contrast, the U.S. market seems to have a stronger ability to recover; for example, Abbott regained its lost market share within a year after the 2022 recall of Similac formula. Whether Nestlé can swiftly curb its losses worldwide depends on its subsequent response speed and transparency.

Risk Warning and DisclaimerThe market has risks, investment requires caution. This article does not constitute personal investment advice and does not take into account individual users' special investment goals, financial circumstances, or needs. Users should consider whether any opinions, views, or conclusions in this article are appropriate for their particular situation. Investing based on this is at your own risk. ```